Loading
A phase 2/3 trial of sintilimab in colorectal cancer, run by Chinese Academy of Medical Sciences, not yet recruiting.
Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer is a phase 2/3, randomised interventional study registered as NCT05484024 by Chinese Academy of Medical Sciences, with a registry enrolment figure of 588 participants, started 2022-08-06 and due to reach its primary completion in 2028-07-31. Interventions recorded: Sintilimab; Short-course radiotherapy; CAPOX/mFOLFOX. Conditions listed: Rectal Neoplasms Malignant; Radiotherapy. Primary outcome: complete remission; Disease-free survival rate. Colorectal eligibility wording from the registry: "* Biopsy proven rectal adenocarcinoma;". Sites: China. No results are recorded here; the registry entry is the source.
Shares Sintilimab, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Sintilimab, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Sintilimab, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Sintilimab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Sintilimab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Sintilimab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Sintilimab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.